Prostaglandin E2(PGE2) induces headache in healthy subjects.
about
Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial.The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.Sources of variability of resting cerebral blood flow in healthy subjects: a study using ¹³³Xe SPECT measurements15th International Headache Congress: basic science highlights.Taking the negative view of current migraine treatments: the unmet needs.Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience.Update on future headache treatments.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.COX inhibitors for the treatment of migraine.Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists.Simulated airplane headache: a proxy towards identification of underlying mechanisms.Risk factors for high-altitude headache in mountaineers.Headache attributed to airplane travel: diagnosis, pathophysiology, and treatment - a systematic review.Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine.Human models of migraine - short-term pain for long-term gain.Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method.Prostaglandin E2 induces immediate migraine-like attack in migraine patients without auraProstaglandin E2 induces immediate migraine-like attack in migraine patients without auraDural mast cell degranulation is a putative mechanism for headache induced by PACAP-38Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in manLack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjectsDiscrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2)
P2860
Q30982450-B1291D8E-0449-4345-A325-F30B2DE2D5CAQ34987458-ABD9E21F-491D-4E52-9F7A-0997EE8FBDFBQ35214562-B42D7F98-37D2-450D-B2B9-9F45C41A2B32Q36839954-6FBF7B11-B708-41C8-9B4B-891EAD07A503Q38001022-66355839-624F-4C04-84A8-4A521D913974Q38004092-1D492F48-B87E-4F05-942B-66700779AE30Q38106681-56D92D17-59E6-41CF-9B3B-8178668B5AC2Q38108486-4305CB67-5192-4F70-AB34-23CBCF756C37Q38130336-5A9D82EC-AF50-44C4-B1C7-D3EEC24DF20EQ38227997-5929BCFC-1A11-4D97-B5CD-4F6160EBE132Q38533414-5A423178-872B-4878-B5C9-C0BF199483C4Q38764879-EBEEC8E7-9443-439E-A645-E5930593D49EQ39795155-231856F6-8137-4B84-B7B8-AE8356403831Q41436081-4A3F3AC5-E005-4D81-92D1-72CE976D5955Q42936119-C313BD1B-DAFD-4C9C-AF73-F83776E3F18FQ47912532-EA6CD9F6-26EB-42DA-9983-62348B06995DQ48273446-D9B1822C-3071-4675-93EA-491C44652330Q57023941-969DB152-1277-452E-B8A4-55297E15558EQ57023979-D2F066CA-B6FD-40AF-93EA-6360D0CFCA60Q57024007-56DCA955-3282-4CD9-841E-3777E5553CE6Q57024045-2042EB96-8408-480C-9569-F25F034174BEQ57024089-CAB2800E-DDE7-4F63-AAF4-4243739F6CCDQ57024118-338A2298-0524-4578-8FA3-02A8212F3013
P2860
Prostaglandin E2(PGE2) induces headache in healthy subjects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prostaglandin E2(PGE2) induces headache in healthy subjects.
@en
type
label
Prostaglandin E2(PGE2) induces headache in healthy subjects.
@en
prefLabel
Prostaglandin E2(PGE2) induces headache in healthy subjects.
@en
P2860
P1433
P1476
Prostaglandin E2(PGE2) induces headache in healthy subjects.
@en
P2093
P2860
P304
P356
10.1111/J.1468-2982.2008.01748.X
P407
P577
2009-02-02T00:00:00Z